Zobrazeno 1 - 10
of 18
pro vyhledávání: '"David P. Sontag"'
Autor:
Steven Horng, David A Sontag, Yoni Halpern, Yacine Jernite, Nathan I Shapiro, Larry A Nathanson
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0174708 (2017)
OBJECTIVE:To demonstrate the incremental benefit of using free text data in addition to vital sign and demographic data to identify patients with suspected infection in the emergency department. METHODS:This was a retrospective, observational cohort
Externí odkaz:
https://doaj.org/article/8bc94f749fd4432a8e0bf7b27949a1c1
Publikováno v:
Journal of Gastroenterology and Hepatology. 36:1103-1109
BACKGROUND AND AIM Cholangiocarcinoma (CCA) is an often fatal primary cancer of the liver that tends to be resistant to chemotherapy. Multidrug resistance proteins (MRPs) contribute to the chemoresistance of these tumors. The objectives of the study
Autor:
Gerald Y. Minuk, David A. Miles, Jiaqi Yang, Julia Uhanova, Micah Grubert Van Iderstine, David P. Sontag
Publikováno v:
Annals of Hepatology, Vol 19, Iss 3, Pp 265-268 (2020)
Introduction and objectives Hepatocellular carcinoma (HCC) can recur following radiofrequency ablation and other hyperthermic treatment modalities. Cancer stem cells (CSCs) are a subpopulation of HCC cells that are difficult to eradicate and largely
Background: Intra- and extra- hepatic cholangiocarcinoma (I-CCA and E-CCA respectively) exhibit different growth features that contribute to different clinical outcomes. Cancer stem cells (CSCs) influence tumor growth and thereby, may be responsible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc98cabd541e8620f6d9dbc3861fa1a2
https://doi.org/10.21203/rs.3.rs-214257/v1
https://doi.org/10.21203/rs.3.rs-214257/v1
Publikováno v:
Journal of Clinical and Translational Hepatology
Background and Aims Fibroblast growth factor (FGF)19 has been implicated in the pathogenesis of murine hepatocellular carcinoma. Whether it plays a role in the development or course of human cholangiocarcinoma remains to be determined. The aim of thi
Publikováno v:
Annals of Hepatology, Vol 21, Iss, Pp 100265-(2021)
Introduction and objectives Intrahepatic (I-CCA) and extrahepatic (E-CCA) cholangiocarcinoma (CCA) have different growth patterns and risks for tumor metastasis. Inhibition and/or activation of the chemokine receptor CCR subclasses have been reported
Publikováno v:
Cardiovascular Toxicology. 13:244-253
The anti-cancer drug doxorubicin is associated with an increased risk of cardiac damage and dysfunction, which can be acute as well as chronic. Fibroblast growth factor 2 (FGF-2) provides cardioprotection from ischemia-reperfusion injury but its effe
Autor:
David P. Sontag, Peter A. Cattini
Publikováno v:
Molecular and Cellular Biochemistry. 242:65-70
Fibroblast growth factor-16 (FGF-16) has been reported as the sixteenth member of the heparin sulphate proteoglycan binding growth factor family, which includes acidic and basic FGFs (FGF-1 and FGF-2), based on sequence similarity. The sequences of h
Publikováno v:
Cytokinegrowth factor reviews. 26(1)
Fibroblast growth factor 16 (FGF-16) was originally cloned from rat heart. Subsequent investigation of mouse FGF-16, including generation of null mice, revealed a specific pattern of expression in the endocardium and epicardium, and role for FGF-16 d
Publikováno v:
American journal of physiology. Cell physiology. 294(5)
FGF-16 has been reported to be preferentially expressed in the adult rat heart. We have investigated the expression of FGF-16 in the perinatal and postnatal heart and its functional significance in neonatal rat cardiac myocytes. FGF-16 mRNA accumulat